Literature DB >> 31607636

Editoral commentary: Understanding cardiovascular disease risk in women with polycystic ovary syndrome.

Melanie Cree-Green1.   

Abstract

Entities:  

Keywords:  Cardiovascular disease; Polycystic ovary syndrome

Mesh：

Year:  2019        PMID： 31607636      PMCID： PMC8809500          DOI： 10.1016/j.tcm.2019.09.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


× No keyword cloud information.
  16 in total

Review 1.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

2.  Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis.

Authors:  Yaqiong Zhou; Xiaoyun Wang; Yongrong Jiang; Honglan Ma; Li Chen; Chenglin Lai; Chunrong Peng; Caiyun He; Chaofeng Sun
Journal:  Gynecol Endocrinol       Date:  2017-07-11       Impact factor: 2.260

3.  Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.

Authors:  Melanie Cree-Green; Anne-Marie Carreau; Haseeb Rahat; Yesenia Garcia-Reyes; Bryan C Bergman; Laura Pyle; Kristen J Nadeau
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-12       Impact factor: 4.310

4.  Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index).

Authors:  Anne-Marie Carreau; Laura Pyle; Yesenia Garcia-Reyes; Haseeb Rahat; Tim Vigers; Thomas Jensen; Ann Scherzinger; Kristen J Nadeau; Melanie Cree-Green
Journal:  Clin Endocrinol (Oxf)       Date:  2019-08-16       Impact factor: 3.478

5.  Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance.

Authors:  Melanie Cree-Green; Bryan C Bergman; Gregory V Coe; Lindsey Newnes; Amy D Baumgartner; Samantha Bacon; Ann Sherzinger; Laura Pyle; Kristen J Nadeau
Journal:  Obesity (Silver Spring)       Date:  2016-11       Impact factor: 5.002

6.  The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.

Authors:  Nadira S Kakoly; Arul Earnest; Helena J Teede; Lisa J Moran; Anju E Joham
Journal:  Diabetes Care       Date:  2019-01-31       Impact factor: 19.112

7.  Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.

Authors:  Rupal Shroff; Craig H Syrop; William Davis; Bradley J Van Voorhis; Anuja Dokras
Journal:  Fertil Steril       Date:  2007-04-26       Impact factor: 7.329

8.  Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.

Authors:  Soulmaz Shorakae; Sanjeeva Ranasinha; Sally Abell; Gavin Lambert; Elisabeth Lambert; Barbora de Courten; Helena Teede
Journal:  Clin Endocrinol (Oxf)       Date:  2018-08-02       Impact factor: 3.478

9.  Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome.

Authors:  Melanie Cree-Green; Haseeb Rahat; Bradley R Newcomer; Bryan C Bergman; Mark S Brown; Gregory V Coe; Lindsey Newnes; Yesenia Garcia-Reyes; Samantha Bacon; Jessica E Thurston; Laura Pyle; Ann Scherzinger; Kristen J Nadeau
Journal:  J Endocr Soc       Date:  2017-06-01

Review 10.  Non-alcoholic fatty liver disease and cardiovascular risk.

Authors:  Rashmee Patil; Gagan K Sood
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.